CN107290417A - A kind of biology sensor for improving reagent crystal habit - Google Patents
A kind of biology sensor for improving reagent crystal habit Download PDFInfo
- Publication number
- CN107290417A CN107290417A CN201710454400.3A CN201710454400A CN107290417A CN 107290417 A CN107290417 A CN 107290417A CN 201710454400 A CN201710454400 A CN 201710454400A CN 107290417 A CN107290417 A CN 107290417A
- Authority
- CN
- China
- Prior art keywords
- detection reagent
- biosensor
- electrode system
- electrode
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 94
- 239000013078 crystal Substances 0.000 title claims abstract description 15
- 238000001514 detection method Methods 0.000 claims abstract description 77
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 239000000126 substance Substances 0.000 claims abstract description 23
- 239000000758 substrate Substances 0.000 claims abstract description 22
- 125000003277 amino group Chemical group 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000005070 sampling Methods 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 4
- 150000002460 imidazoles Chemical class 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 claims description 2
- YBCAZPLXEGKKFM-UHFFFAOYSA-K ruthenium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Ru+3] YBCAZPLXEGKKFM-UHFFFAOYSA-K 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 description 40
- 239000010410 layer Substances 0.000 description 34
- 239000007864 aqueous solution Substances 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 17
- 238000010586 diagram Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 7
- 108010015776 Glucose oxidase Proteins 0.000 description 7
- 239000004366 Glucose oxidase Substances 0.000 description 7
- 239000013504 Triton X-100 Substances 0.000 description 7
- 229920004890 Triton X-100 Polymers 0.000 description 7
- 229940116332 glucose oxidase Drugs 0.000 description 7
- 235000019420 glucose oxidase Nutrition 0.000 description 7
- 229920000609 methyl cellulose Polymers 0.000 description 7
- 239000001923 methylcellulose Substances 0.000 description 7
- 239000012064 sodium phosphate buffer Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 6
- 238000007650 screen-printing Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000011810 insulating material Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 229960001153 serine Drugs 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- -1 antibodies Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012612 commercial material Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000007772 electrode material Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000010147 laser engraving Methods 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GBDZMMXUOBAJMN-UHFFFAOYSA-K azane;ruthenium(3+);trichloride Chemical compound N.N.N.N.N.N.[Cl-].[Cl-].[Cl-].[Ru+3] GBDZMMXUOBAJMN-UHFFFAOYSA-K 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种改进试剂结晶形态的生物传感器,从下至上依次包括绝缘基板、电极系统、中隔层和覆盖层;所述电极系统至少包括工作电极和对电极;所述电极系统上固定至少覆盖工作电极的检测试剂;所述中隔层在样本通道及反应室区域镂空;所述覆盖层和中隔层及绝缘基板构建成反应室及进样毛细通道;所述反应室具有透气孔;所述检测试剂的组成包含具有氨基的化学物质。本发明在检测试剂组分中加入具有氨基的化学物质后,能有效消除或降低检测试剂固化后的“咖啡圈”现象,使检测试剂在电极系统上的形态更加均匀、细致和一致,显著提升了生物传感器产品测试精密度性能。特别是以六氨三氯化钌为电子介体的检测试剂,本发明的效果非常显著。
The invention discloses a biosensor for improving the crystal form of reagents, which comprises an insulating substrate, an electrode system, an intermediate layer and a covering layer from bottom to top; the electrode system includes at least a working electrode and a counter electrode; the electrode system is fixed on the Cover at least the detection reagent of the working electrode; the intermediate layer is hollowed out in the sample channel and the reaction chamber area; the covering layer and the intermediate layer and the insulating substrate are constructed into a reaction chamber and a sampling capillary channel; the reaction chamber has air holes ; The composition of the detection reagent contains chemical substances with amino groups. The present invention can effectively eliminate or reduce the "coffee ring" phenomenon after the detection reagent is cured after adding the chemical substance with amino group to the detection reagent component, making the shape of the detection reagent on the electrode system more uniform, meticulous and consistent, and significantly improving The precision performance of biosensor products is tested. In particular, the detection reagent using hexaamine ruthenium trichloride as the electron mediator has very remarkable effect.
Description
技术领域technical field
本发明涉及生物检测仪器领域,具体涉及一种改进试剂结晶形态的生物传感器。The invention relates to the field of biological detection instruments, in particular to a biosensor for improving the crystal form of reagents.
背景技术Background technique
生物传感器(biosensor),是一种对生物物质敏感并将其浓度转换为电信号进行检测的仪器。是由固定化的生物敏感材料作识别元件(包括酶、抗体、抗原、微生物、细胞、组织、核酸等生物活性物质)、适当的理化换能器(如氧电极、光敏管、场效应管、压电晶体等等)及信号放大装置构成的分析工具或系统。A biosensor is an instrument that is sensitive to biological substances and converts its concentration into an electrical signal for detection. It is made of immobilized biosensitive materials as recognition elements (including enzymes, antibodies, antigens, microorganisms, cells, tissues, nucleic acids and other biologically active substances), appropriate physical and chemical transducers (such as oxygen electrodes, photosensitive tubes, field effect tubes, Piezoelectric crystals, etc.) and an analysis tool or system composed of a signal amplification device.
电化学生物传感器已经被广泛应用于体外诊断领域,这些仪器系统能检测体液中的生理物质,方便医生对病人状况分析和诊断,也有一些仪器系统应用到家庭使用,方便病人的自我监控,这些生理指标包括血糖、胆固醇、尿酸、甘油三酸酯、乳酸、酮体、酶类等。目前生物传感器已经被广泛应用于临床检测中,其中最普及的例子是便携式血糖测试系统。Electrochemical biosensors have been widely used in the field of in vitro diagnostics. These instrument systems can detect physiological substances in body fluids, which is convenient for doctors to analyze and diagnose patients' conditions. Some instrument systems are also used at home to facilitate self-monitoring of patients. These physiological Indicators include blood sugar, cholesterol, uric acid, triglycerides, lactic acid, ketone bodies, enzymes, etc. At present, biosensors have been widely used in clinical testing, and the most popular example is a portable blood glucose testing system.
目前的生物传感器测试片通常有以下几个部分组成:绝缘基板,作为产品的载体;构建在绝缘基板上的电极系统,至少包括工作电极和对电极;固定在电极系统上的检测试剂;中隔层,反应室及进样通道处开口,覆在电极系统上;覆盖层,覆盖在中隔层上,和基板、中隔层一起构成反应室。The current biosensor test piece usually consists of the following parts: an insulating substrate, as a carrier of the product; an electrode system built on the insulating substrate, including at least a working electrode and a counter electrode; a detection reagent fixed on the electrode system; a septum The opening of the reaction chamber and the sampling channel covers the electrode system; the covering layer covers the intermediate layer and forms the reaction chamber together with the substrate and the intermediate layer.
临床使用的生物传感器产品的精密度性能非常重要,其中工作电极上的检测试剂结晶形态是否一致直接影响了产品的精密度性能。但是,目前检测试剂结晶形态技术上普遍存在的难题是“咖啡圈”现象,特别是采用六铵三氯化钌为电子介体的检测试剂,具体表现是试剂固化后边缘高中间低、或者形态呈花斑状、颗粒粗不均匀,直接导致试剂在电极上分布厚薄不均、反应不一致,是产品进一步提升精密度性能的主要障碍之一。The precision performance of clinically used biosensor products is very important, and whether the crystal form of the detection reagent on the working electrode is consistent directly affects the precision performance of the product. However, at present, the common problem in the detection reagent crystal morphology technology is the "coffee ring" phenomenon, especially the detection reagent using hexammonium ruthenium trichloride as the electron mediator, the specific performance is that the edge is high and the middle is low after the reagent is solidified, or the shape Mottled, coarse and uneven particles directly lead to uneven distribution of reagents on the electrode and inconsistent reactions, which is one of the main obstacles to further improving the precision performance of the product.
发明内容Contents of the invention
为克服上述现有技术存在的缺陷,本发明旨在提供一种检测试剂结晶形态均匀、测试精密度好的生物传感器,从而解决现有技术普遍存在的难题—“咖啡圈”现象。In order to overcome the above-mentioned defects in the prior art, the present invention aims to provide a biosensor with uniform crystal morphology of the detection reagent and good test precision, so as to solve the ubiquitous problem in the prior art - the "coffee ring" phenomenon.
本发明的目的是通过以下技术方案实现的:一种改进试剂结晶形态的生物传感器,可用于检测样本中特定物质浓度或活性,其组成包含:绝缘基板;构建在绝缘基板上的电极系统,所述的电极系统至少包括工作电极和对电极;固定在电极系统上且至少应该覆盖工作电极的检测试剂;构建在电极系统上方的中隔层,所述的中隔层在样本通道及反应室区域镂空;设在中隔层上方的覆盖层,所述的覆盖层和中隔层及绝缘基板构建成反应室及进样毛细通道,样本可通过毛细虹吸作用自动进样;所述的反应室应有透气孔,以便形成虹吸作用;其中,所述的检测试剂的组成包含具有氨基的化学物质。The purpose of the present invention is achieved through the following technical solutions: a biosensor with improved reagent crystallization form can be used to detect the concentration or activity of specific substances in samples, and its composition includes: an insulating substrate; an electrode system built on the insulating substrate, the The electrode system includes at least a working electrode and a counter electrode; a detection reagent that is fixed on the electrode system and should at least cover the working electrode; hollowed out; the covering layer arranged above the intermediate layer, the covering layer, the intermediate layer and the insulating substrate are constructed into a reaction chamber and a sampling capillary channel, and the sample can be automatically injected by capillary siphon; the reaction chamber should There are air holes to form a siphon effect; wherein, the composition of the detection reagent contains chemical substances with amino groups.
绝缘基板是生物传感器的载体。本发明中,绝缘基板优选的是具有一定挺度的柔性塑料片材,包括但不限于PET、PP、PVC、亚克力等材料。目前有多种商业化的产品可供选择,如Dupont公司ST 504、ST 339等。The insulating substrate is the carrier of the biosensor. In the present invention, the insulating substrate is preferably a flexible plastic sheet with a certain stiffness, including but not limited to PET, PP, PVC, acrylic and other materials. There are currently a variety of commercial products to choose from, such as Dupont's ST 504, ST 339, etc.
电极系统构建在绝缘基板上,至少包括对电极和工作电极。电极的材料包括但不限于石墨、银、金、铂、钯、ITO、IZO中的一种,可以通过丝网印刷、真空溅镀结合激光加工等工艺构建在绝缘基板上。The electrode system is built on an insulating substrate, including at least a counter electrode and a working electrode. The electrode material includes but is not limited to one of graphite, silver, gold, platinum, palladium, ITO, and IZO, which can be constructed on an insulating substrate by screen printing, vacuum sputtering, and laser processing.
中隔层,构建在电极系统上方,反应室区域镂空,结合覆盖层形成了反应室即进样通道。所述的中隔层的厚度为0.025mm~0.5mm,作为优选,中隔层的厚度为0.075mm~0.125mm。中隔层材料可以是带基材或不带基材的胶带,加工好后粘合上去;也可以是胶或聚合物浆料,通过丝网印刷上去;如电极上无其他绝缘材料隔开,中隔层的材料必须是良好的绝缘材料。The intermediate layer is built above the electrode system, and the reaction chamber area is hollowed out. Combined with the cover layer, the reaction chamber, that is, the sampling channel, is formed. The thickness of the intermediate layer is 0.025 mm to 0.5 mm, preferably, the thickness of the intermediate layer is 0.075 mm to 0.125 mm. The material of the intermediate layer can be a tape with or without a base material, which is bonded after processing; it can also be glue or polymer paste, which is printed on by screen printing; if there is no other insulating material on the electrode, The material of the intermediate layer must be a good insulating material.
覆盖层,在中隔层上方,和中隔层、绝缘基板构建成反应室及进样通道,以便通过虹吸作用自动进样。覆盖层可使用PET材料,优选透明的亲水处理过的材料,透明能帮助用户容易确认反应区进样状态,亲水能使进样更为顺畅,非反应室区域可以不透明,印刷进样标志和Logo,可用的商业化材料有Adhesives Research,Inc的92804、Coveme公司Kemafoil HHNW、3M公司的9971等。The cover layer, above the intermediate layer, together with the intermediate layer and the insulating substrate are constructed into a reaction chamber and a sample injection channel, so as to automatically inject samples through siphon action. PET material can be used for the cover layer, preferably transparent hydrophilic treated material, transparent can help users easily confirm the sample injection status in the reaction area, hydrophilic can make the sample injection smoother, non-reaction chamber area can be opaque, and the sample injection logo can be printed and Logo, available commercial materials are Adhesives Research, Inc's 92804, Kemafoil HHNW of Coveme Company, 9971 of 3M Company, etc.
透气孔,反应室应有透气孔,以便形成虹吸作用,透气孔通过覆盖层或绝缘基板进样通道尾端区域打孔实现,也可通过中隔层在进样通道尾端区域留出通气口实现。Vent holes, the reaction chamber should have vent holes to form a siphon effect, and the vent holes can be realized by punching holes in the tail end area of the sampling channel on the cover layer or insulating substrate, or a vent can be left in the tail end area of the sampling channel through the middle compartment accomplish.
检测试剂是生物传感器核心技术之一。检测试剂固定在电极系统的上面,应至少覆盖工作电极。检测试剂可以通过点液、丝网印刷、喷墨打印、夹缝挤出等技术加工固定到电极上。检测试剂包含酶、电子介体、缓冲液、表面活性剂、多聚物等组分。酶的作用是特异性的和被检测物反应;电子介体从酶和被检测物的反应中获取电子,并扩散到电极上释放电子,并形成信号,该信号可以被测试仪捕获;缓冲液保证一个合适的反应环境;表面活性剂能够优化反应条件,并促进样本扩散;多聚物能形成网架结构,并一定程度上固定酶。Detection reagent is one of the core technologies of biosensors. The detection reagent is fixed on the electrode system and should at least cover the working electrode. The detection reagent can be processed and fixed on the electrode by spotting, screen printing, inkjet printing, slot extrusion and other technologies. Detection reagents include enzymes, electron mediators, buffers, surfactants, polymers and other components. The role of the enzyme is to specifically react with the analyte; the electron mediator obtains electrons from the reaction between the enzyme and the analyte, and diffuses to the electrode to release electrons and form a signal, which can be captured by the tester; buffer Ensure a suitable reaction environment; surfactants can optimize reaction conditions and promote sample diffusion; polymers can form a network structure and immobilize enzymes to a certain extent.
本发明的主要特征是检测试剂中包含具有氨基的化学物质,该物质具有的化学通式如下:Main feature of the present invention is to comprise the chemical substance that has amino group in the detection reagent, and the chemical general formula that this substance has is as follows:
上述化学通式的R1、R2、R3可变基团包括不限于H、烃基、酰基以及烃基的衍生物、酰基的衍生物,R1、R2、R3基团的两个或全部三个基团可以形成环状。该化学通式中典型的物质包括氨基酸(如丝氨酸、苏氨酸、脯氨酸、丙氨酸、赖氨酸、组氨酸、赖氨酸等)、咪唑及咪唑衍生物。The R1, R2, R3 variable groups of the above chemical general formula include not limited to H, hydrocarbon groups, acyl groups and derivatives of hydrocarbon groups, acyl derivatives, and two or all three groups of R1, R2, R3 groups can be Form a ring. Typical substances in this chemical formula include amino acids (such as serine, threonine, proline, alanine, lysine, histidine, lysine, etc.), imidazole and imidazole derivatives.
发明人研究发现,检测试剂中加入具有氨基的化学物质后,能有效消除或降低检测试剂固化后的“咖啡圈”现象,使检测试剂在电极系统上的形态更加均匀、细致和一致,显著提升了生物传感器产品测试精密度性能。特别是以六氨三氯化钌为电子介体的检测试剂,本发明的效果非常显著。The inventors have found that adding chemical substances with amino groups to the detection reagent can effectively eliminate or reduce the "coffee ring" phenomenon after the detection reagent is solidified, making the shape of the detection reagent on the electrode system more uniform, detailed and consistent, and significantly improving Test precision performance of biosensor products. In particular, the detection reagent using hexaamine ruthenium trichloride as the electron mediator has very remarkable effect.
本发明中,具有氨基的化学物质在检测试剂配制溶液中的浓度可以为1mM~500mM,优选10mM~100mM。In the present invention, the concentration of the chemical substance having an amino group in the detection reagent preparation solution may be 1 mM-500 mM, preferably 10 mM-100 mM.
与现有技术相比,本发明具有以下优点:Compared with the prior art, the present invention has the following advantages:
本发明在检测试剂组分中加入具有氨基的化学物质后,能有效消除或降低检测试剂固化后的“咖啡圈”现象,使检测试剂在电极系统上的形态更加均匀、细致和一致,显著提升了生物传感器产品测试精密度性能。特别是以六氨三氯化钌为电子介体的检测试剂,本发明的效果非常显著。The present invention can effectively eliminate or reduce the "coffee ring" phenomenon after the detection reagent is cured after adding the chemical substance with amino group to the detection reagent component, making the shape of the detection reagent on the electrode system more uniform, meticulous and consistent, and significantly improving Test precision performance of biosensor products. In particular, the detection reagent using hexaamine ruthenium trichloride as the electron mediator has very remarkable effect.
实验测试结果表明,对照例同一浓度反应曲线离散性较大、精密度不是非常理想;而本发明实施例的同一浓度反应曲线非常一致,生物传感器的精密度得到了显著改善。The experimental test results show that the same concentration response curve of the control example has large dispersion and the precision is not very ideal; while the same concentration response curve of the embodiment of the present invention is very consistent, and the precision of the biosensor has been significantly improved.
附图说明Description of drawings
图1A和图1B分别是本发明的一种改进试剂结晶形态的生物传感器的结构分解示意图和结构完整示意图。FIG. 1A and FIG. 1B are respectively a schematic diagram of an exploded structure and a schematic diagram of a complete structure of a biosensor with improved reagent crystal form according to the present invention.
图2是本发明的一种改进试剂结晶形态的生物传感器的电极系统结构示意图。Fig. 2 is a schematic structural view of the electrode system of a biosensor with improved reagent crystal form according to the present invention.
图3是对照例1的检测试剂结晶形态图。FIG. 3 is a crystallographic diagram of the detection reagent of Comparative Example 1.
图4是本发明实施例1的检测试剂结晶形态图。Fig. 4 is a crystallographic diagram of the detection reagent of Example 1 of the present invention.
图5是本发明实施例2的检测试剂结晶形态图。Fig. 5 is a crystallographic diagram of the detection reagent of Example 2 of the present invention.
图6是本发明实施例3的检测试剂结晶形态图。Fig. 6 is a crystallographic diagram of the detection reagent of Example 3 of the present invention.
图7是本发明实施例4的检测试剂结晶形态图。Fig. 7 is a crystallographic diagram of the detection reagent of Example 4 of the present invention.
图8是本发明实施例5的检测试剂结晶形态图。Fig. 8 is a crystallographic diagram of the detection reagent of Example 5 of the present invention.
图9是本发明实施例6的检测试剂结晶形态图。Fig. 9 is a crystallographic diagram of the detection reagent of Example 6 of the present invention.
图10对照例1的反应曲线图。Figure 10 is a response curve diagram of Comparative Example 1.
图11本发明实施例1的反应曲线图。Fig. 11 is a reaction curve diagram of Example 1 of the present invention.
图12本发明实施例2的反应曲线图。Fig. 12 is the reaction curve diagram of Example 2 of the present invention.
图13本发明实施例3的反应曲线图。Fig. 13 is a reaction curve diagram of Example 3 of the present invention.
图14本发明实施例4的反应曲线图。Fig. 14 is the reaction curve diagram of Example 4 of the present invention.
图15本发明实施例5的反应曲线图。Fig. 15 is a reaction curve diagram of Example 5 of the present invention.
图16本发明实施例6的反应曲线图。Fig. 16 is a reaction curve diagram of Example 6 of the present invention.
具体实施方式detailed description
下面结合实施例和附图,更具体地说明本发明的内容。应当理解,本发明的实施并不局限于下面的实施例,对本发明所做的任何形式上的变通和/或改变都将落入本发明保护范围。The content of the present invention will be described in more detail below in conjunction with the embodiments and accompanying drawings. It should be understood that the implementation of the present invention is not limited to the following examples, and any modifications and/or changes made to the present invention will fall within the protection scope of the present invention.
在本发明中,若非特指,所有的设备和原料等均可从市场购得或是本行业常用的。下述实施例中的方法,如无特别说明,均为本领域的常规方法。In the present invention, unless otherwise specified, all equipment and raw materials can be purchased from the market or commonly used in this industry. The methods in the following examples, unless otherwise specified, are conventional methods in the art.
实施例中的生物传感器测试片构成说明:Description of the composition of the biosensor test piece in the embodiment:
绝缘基板,材质包括但不限于PET、PP、PVC、亚克力中的一种。Insulating substrate, the material includes but not limited to one of PET, PP, PVC, and acrylic.
电极系统,构建在绝缘基板上。电极系统包括第一对电极、工作电极、第二对电极,第一对电极、工作电极、第二对电极从进样口到反应通道远端依次排列。电极的材料包括但不限于石墨、银、金、铂、钯、ITO、IZO中的一种,可以通过丝网印刷、真空溅镀结合激光加工等工艺构建在绝缘基板上。Electrode system, built on an insulating substrate. The electrode system includes a first pair of electrodes, a working electrode, and a second pair of electrodes, and the first pair of electrodes, the working electrode, and the second pair of electrodes are arranged sequentially from the sample inlet to the far end of the reaction channel. The electrode material includes but is not limited to one of graphite, silver, gold, platinum, palladium, ITO, and IZO, which can be constructed on an insulating substrate by screen printing, vacuum sputtering, and laser processing.
检测试剂,固定在电极系统上,至少覆盖工作电极。检测试剂先配制成溶液或浆料,然后通过喷点、丝网印刷、夹缝挤出、喷墨打印等工艺固定到电极系统上。本发明以葡萄糖检测试剂作为实施例。The detection reagent, fixed on the electrode system, covers at least the working electrode. The detection reagent is first prepared into a solution or slurry, and then fixed on the electrode system by spraying, screen printing, slot extrusion, inkjet printing and other processes. The present invention takes the glucose detection reagent as an example.
中隔层构建在电极系统上方,反应室区域镂空,结合覆盖层形成了反应室即进样通道。所述的中隔层的厚度为0.025mm~0.5mm,作为优选,中隔层的厚度为0.075mm~0.125mm。中隔层的材料可以是带基材或不带基材的胶带,加工好后粘合上去;也可以是胶或聚合物浆料,通过丝网印刷上去;如电极上无其他绝缘材料隔开,中隔层的材料必须是良好的绝缘材料。The intermediate layer is built above the electrode system, and the reaction chamber area is hollowed out, and combined with the cover layer, the reaction chamber, that is, the sampling channel, is formed. The thickness of the intermediate layer is 0.025 mm to 0.5 mm, preferably, the thickness of the intermediate layer is 0.075 mm to 0.125 mm. The material of the middle layer can be a tape with or without a base material, which is bonded after processing; it can also be glue or polymer paste, which is printed by screen printing; if there is no other insulating material on the electrode , The material of the intermediate layer must be a good insulating material.
覆盖层,在中隔层上方,和中隔层、绝缘基板构建成反应室即进样通道,以便通过虹吸作用自动进样。覆盖层可使用PET材料,优选透明的亲水处理过的材料,透明能帮助用户容易确认反应区进样状态,亲水能使进样更为顺畅,非反应室区域可以不透明,印刷进样标志和Logo,可用的商业化材料有Adhesives Research,Inc的92804、Coveme公司Kemafoil HHNW、3M公司的9971亲水膜等。The cover layer, above the intermediate layer, and the intermediate layer and the insulating substrate are constructed to form a reaction chamber, that is, a sampling channel, so as to automatically inject samples through siphon action. PET material can be used for the cover layer, preferably transparent hydrophilic treated material, transparent can help users easily confirm the sample injection status in the reaction area, hydrophilic can make the sample injection smoother, non-reaction chamber area can be opaque, and the sample injection logo can be printed and Logo, available commercial materials are Adhesives Research, Inc's 92804, Kemafoil HHNW of Coveme Company, 9971 hydrophilic membrane of 3M Company, etc.
反应室应有透气孔,以便形成虹吸作用,本发明实施例的透气孔通过覆盖层进样通道尾端区域打孔实现。The reaction chamber should have air holes so as to form a siphon effect, and the air holes in the embodiment of the present invention are realized by punching holes in the tail end area of the sampling channel in the covering layer.
对照例1Comparative example 1
生物传感器的结构如图1A、图1B和图2所示。绝缘基板100上构建电极系统200;所述的电极系统200包含三个电极:第一对电极201、工作电极202、第二对电极203,电极采用碳电极,通过在绝缘基板100上丝网印刷碳浆固化形成;电极系统上方固定检测试剂300,检测试剂至少覆盖工作电极,通过点胶机分配检测试剂溶液到电极上干燥制作;中隔层400采用双面胶材料,厚度选用0.1mm,中隔层通过激光雕刻或模具切割镂空制作出进样通道及反应室开孔,中隔层贴合在电极系统上;覆盖层500采用透明亲水片材,通过激光雕刻或模具切割在对应反应室末端为主制作出透气孔501,覆盖层500贴合在中隔层上,覆盖层和中隔层及绝缘基板构建成反应室及进样通道401,可通过虹吸作用自动进样;然后使用机器压紧制成完整的生物传感器测试片600,中隔层400开孔的一端为进样口601,电极系统200的每条电极引线向生物传感器测试片另外一端延伸形成连接触脚602,连接触脚端插入检测仪器端口,每条电极的连接触脚会和端口内对应的触点相连。The structure of the biosensor is shown in Figure 1A, Figure 1B and Figure 2. An electrode system 200 is built on the insulating substrate 100; the electrode system 200 includes three electrodes: a first pair of electrodes 201, a working electrode 202, and a second pair of electrodes 203. The carbon slurry is solidified and formed; the detection reagent 300 is fixed above the electrode system, the detection reagent covers at least the working electrode, and the detection reagent solution is distributed on the electrode by a glue dispenser to dry; The interlayer is hollowed out by laser engraving or mold cutting to make the sample injection channel and the opening of the reaction chamber, and the middle interlayer is attached to the electrode system; the covering layer 500 is made of transparent hydrophilic sheet, which is placed in the corresponding reaction chamber by laser engraving or mold cutting The air vent 501 is mainly made at the end, and the cover layer 500 is attached to the middle layer. The cover layer, the middle layer and the insulating substrate are constructed into a reaction chamber and a sample injection channel 401, which can automatically inject samples through a siphon; then use the machine Press to make a complete biosensor test piece 600, one end of the opening of the middle compartment 400 is a sample inlet 601, and each electrode lead wire of the electrode system 200 extends to the other end of the biosensor test piece to form a connecting contact pin 602. The pin end is inserted into the port of the detection instrument, and the connecting contact pin of each electrode will be connected with the corresponding contact in the port.
其中检测试剂300先配制成水溶液,其成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),1.86%(w/v)六氨合三氯化钌(CMI 8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。Wherein detection reagent 300 is formulated into aqueous solution first, and its composition is as follows: 100mM sodium phosphate buffer solution (pH is 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol Alcohol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 1.86% (w/v) hexaamine ruthenium trichloride (CMI 8015), 2000U/mL glucose oxidase (BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
实施例1Example 1
实施例1的生物传感器结构同对照例1,只是检测试剂组分不同。The structure of the biosensor of Example 1 is the same as that of Comparative Example 1, except that the detection reagent components are different.
检测试剂水溶液成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),50mM咪唑(阿拉丁试剂I108707),1.86%(w/v)六氨合三氯化钌(CMI8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。The composition of the detection reagent aqueous solution is as follows: 100mM sodium phosphate buffer (pH 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 50mM imidazole (Aladdin reagent I108707), 1.86% (w/v) hexaamine ruthenium trichloride (CMI8015), 2000U/mL glucose oxidase ( BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
实施例2Example 2
实施例2的生物传感器结构同对照例1,只是检测试剂组分不同。The structure of the biosensor of Example 2 is the same as that of Comparative Example 1, except that the detection reagent components are different.
检测试剂水溶液成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),50mM L-苏氨酸(阿拉丁试剂T108221),1.86%(w/v)六氨合三氯化钌(CMI 8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。The composition of the detection reagent aqueous solution is as follows: 100mM sodium phosphate buffer (pH 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 50mM L-threonine (Aladdin reagent T108221), 1.86% (w/v) hexaamine ruthenium trichloride (CMI 8015), 2000U/ mL glucose oxidase (BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
实施例3Example 3
实施例3的生物传感器结构同对照例1,只是检测试剂组分不同。The structure of the biosensor of Example 3 is the same as that of Comparative Example 1, except that the detection reagent components are different.
检测试剂水溶液成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),50mM L-脯氨酸(阿拉丁试剂P108709),1.86%(w/v)六氨合三氯化钌(CMI 8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。The composition of the detection reagent aqueous solution is as follows: 100mM sodium phosphate buffer (pH 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 50mM L-proline (Aladdin reagent P108709), 1.86% (w/v) hexaamine ruthenium trichloride (CMI 8015), 2000U/ mL glucose oxidase (BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
实施例4Example 4
实施例4的生物传感器结构同对照例1,只是检测试剂组分不同。The structure of the biosensor of Example 4 is the same as that of Comparative Example 1, except that the detection reagent components are different.
检测试剂水溶液成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),50mM L-丝氨酸(阿拉丁试剂S103483),1.86%(w/v)六氨合三氯化钌(CMI 8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。The composition of the detection reagent aqueous solution is as follows: 100mM sodium phosphate buffer (pH 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 50mM L-serine (Aladdin reagent S103483), 1.86% (w/v) hexaamine ruthenium trichloride (CMI 8015), 2000U/mL glucose Oxidase (BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
实施例5Example 5
实施例5的生物传感器结构同对照例1,只是检测试剂组分不同.The biosensor structure of Example 5 is the same as that of Comparative Example 1, except that the detection reagent components are different.
检测试剂水溶液成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),10mM L-丝氨酸(阿拉丁试剂S103483),1.86%(w/v)六氨合三氯化钌(CMI 8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。The composition of the detection reagent aqueous solution is as follows: 100mM sodium phosphate buffer (pH 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 10mM L-serine (Aladdin reagent S103483), 1.86% (w/v) hexaamine ruthenium trichloride (CMI 8015), 2000U/mL glucose Oxidase (BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
实施例6Example 6
实施例6的生物传感器结构同对照例1,只是检测试剂组分不同.The biosensor structure of Example 6 is the same as that of Comparative Example 1, except that the detection reagent components are different.
检测试剂水溶液成分如下:100mM磷酸钠缓冲液(pH为7.0),1.2%(w/v)甲基纤维素(Sigma M6385),0.5%(w/v)聚乙二醇4000(Sigma 95904),0.5%(w/v)Triton X-100(Aladdin T109026),100mM L-丝氨酸(阿拉丁试剂S103483),1.86%(w/v)六氨合三氯化钌(CMI 8015),2000U/mL葡萄糖氧化酶(BBI Solutions GO3A)。检测试剂水溶液使用点胶机分配固定到生物传感器测试片的电极系统上,每条生物传感器测试片分配1.0uL检测试剂水溶液,然后置于60摄氏度烘箱中10分钟干燥。The composition of the detection reagent aqueous solution is as follows: 100mM sodium phosphate buffer (pH 7.0), 1.2% (w/v) methylcellulose (Sigma M6385), 0.5% (w/v) polyethylene glycol 4000 (Sigma 95904), 0.5% (w/v) Triton X-100 (Aladdin T109026), 100mM L-serine (Aladdin reagent S103483), 1.86% (w/v) hexaamine ruthenium trichloride (CMI 8015), 2000U/mL glucose Oxidase (BBI Solutions GO3A). The detection reagent aqueous solution was dispensed and fixed on the electrode system of the biosensor test piece using a dispenser, and each biosensor test piece was dispensed with 1.0uL detection reagent aqueous solution, and then placed in an oven at 60 degrees Celsius for 10 minutes to dry.
测试例test case
使用肝素抗凝的静脉全血,调配成贯穿0~700mg/dL区间的7个葡萄糖浓度水平的样本,其中低浓度样本可以通过血样放置糖酵解获取,高浓度样本可通过加入高浓度葡萄糖溶液调制,实际调配的浓度为:0mg/dL、58.4mg/dL、115.7mg/dL、174.2mg/dL、291.5mg/dL、432.6mg/dL、645.6mg/dL。将上述对照例1及实施例1-6的7种生物传感器测试片在测试仪器上进行测试比对,仪器工作电极和对电极的电位差设置为0.30V,每种试片每个浓度样品测试5条,测试结果采用5秒电流。Use venous whole blood anticoagulated with heparin to prepare samples of 7 glucose concentration levels that run through the range of 0-700 mg/dL. Low-concentration samples can be obtained by glycolysis of blood samples, and high-concentration samples can be obtained by adding high-concentration glucose solution Preparation, the actual preparation concentration is: 0mg/dL, 58.4mg/dL, 115.7mg/dL, 174.2mg/dL, 291.5mg/dL, 432.6mg/dL, 645.6mg/dL. The 7 kinds of biosensor test pieces of the above-mentioned comparative example 1 and embodiment 1-6 are tested and compared on the test instrument, the potential difference between the working electrode and the counter electrode of the instrument is set to 0.30V, and each concentration sample of each test piece is tested 5, the test result uses a 5-second current.
实施例1-6和比较例1的测试结果见图3~图16和如下表1-7。The test results of Examples 1-6 and Comparative Example 1 are shown in Figures 3 to 16 and the following Tables 1-7.
表1:对照例1测试结果Table 1: Test results of control example 1
表2:实施例1测试结果Table 2: Example 1 test results
表3:实施例2测试结果Table 3: Example 2 test results
表4:实施例3测试结果Table 4: Example 3 test results
表5:实施例4测试结果Table 5: Example 4 test results
表6:实施例5测试结果Table 6: Example 5 test results
表7:实施例6测试结果Table 7: Example 6 test results
从表1~表7可以看出,实施例1-6的除0浓度外,变异系数均值比对照例1显著降低(0浓度因数值太低,变异系数相对变化太大,不纳入比对),对照例1变异系数均值为3.1%,实施例变异系数均值为1.0%~2.0%,可见本发明能有效改善生物传感器试片的测试精密度。As can be seen from Table 1 to Table 7, except for the 0 concentration, the average value of the coefficient of variation of Examples 1-6 is significantly lower than that of the control example 1 (the value of the 0 concentration factor is too low, and the relative variation of the coefficient of variation is too large, so it is not included in the comparison) , the average coefficient of variation of Comparative Example 1 is 3.1%, and the average coefficient of variation of Examples is 1.0% to 2.0%. It can be seen that the present invention can effectively improve the test precision of the biosensor test piece.
图3~图9为对照例1及实施例1-6的检测试剂结晶形态图。可见对照例1的“咖啡圈”现象显著,检测试剂形态非常不均一;而六个实施例的检测试剂结晶形态良好、均一一致,无显著“咖啡圈”现象。3 to 9 are the crystal morphology diagrams of the detection reagents of Comparative Example 1 and Examples 1-6. It can be seen that the "coffee ring" phenomenon in Comparative Example 1 is significant, and the morphology of the detection reagent is very heterogeneous; while the detection reagents in the six embodiments have good crystallization morphology and are uniform, without significant "coffee ring" phenomenon.
图10~图16为对照例1及实施例1-6的7个浓度测试反应曲线图。可见对照例同一浓度反应曲线离散性较大,说明对照例的生物传感器的精密度不是非常理想;而六个实施例的同一浓度反应曲线非常一致,说明本发明的生物传感器的精密度得到了显著改善。Figures 10 to 16 are response curves of seven concentration tests of Comparative Example 1 and Examples 1-6. It can be seen that the same concentration-response curve of the comparative example is more discrete, indicating that the precision of the biosensor of the comparative example is not very ideal; and the same concentration-response curves of the six examples are very consistent, indicating that the precision of the biosensor of the present invention has been significantly improved. improve.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710454400.3A CN107290417A (en) | 2017-06-15 | 2017-06-15 | A kind of biology sensor for improving reagent crystal habit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710454400.3A CN107290417A (en) | 2017-06-15 | 2017-06-15 | A kind of biology sensor for improving reagent crystal habit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107290417A true CN107290417A (en) | 2017-10-24 |
Family
ID=60096578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710454400.3A Pending CN107290417A (en) | 2017-06-15 | 2017-06-15 | A kind of biology sensor for improving reagent crystal habit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107290417A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108896635A (en) * | 2018-09-20 | 2018-11-27 | 江苏鱼跃医疗设备股份有限公司 | A kind of beta-hydroxybutyric acid electrochemical sensor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120138484A1 (en) * | 2010-12-03 | 2012-06-07 | Abbott Diabetes Care Inc. | Analyte Sensors Comprising Thickeners, Enzyme Stabilizers and Osmium Boronates |
CN106124595A (en) * | 2016-06-17 | 2016-11-16 | 浙江亿联健医疗器械有限公司 | A kind of biosensor and preparation method thereof and reaction reagent |
CN106226379A (en) * | 2016-07-10 | 2016-12-14 | 浙江亿联健医疗器械有限公司 | A kind of biosensor eliminating sample introduction process influence and method of testing |
-
2017
- 2017-06-15 CN CN201710454400.3A patent/CN107290417A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120138484A1 (en) * | 2010-12-03 | 2012-06-07 | Abbott Diabetes Care Inc. | Analyte Sensors Comprising Thickeners, Enzyme Stabilizers and Osmium Boronates |
CN106124595A (en) * | 2016-06-17 | 2016-11-16 | 浙江亿联健医疗器械有限公司 | A kind of biosensor and preparation method thereof and reaction reagent |
CN106226379A (en) * | 2016-07-10 | 2016-12-14 | 浙江亿联健医疗器械有限公司 | A kind of biosensor eliminating sample introduction process influence and method of testing |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108896635A (en) * | 2018-09-20 | 2018-11-27 | 江苏鱼跃医疗设备股份有限公司 | A kind of beta-hydroxybutyric acid electrochemical sensor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1184470C (en) | Bi-mediator-based glucose biosensor and its use method | |
CN1142427C (en) | Biological sensor | |
CN1188697C (en) | Biological sensor with porous chromatograph diaphragm | |
CN1172181C (en) | biological sensor | |
Parrilla et al. | based enzymatic electrode with enhanced potentiometric response for monitoring glucose in biological fluids | |
KR100446468B1 (en) | Biosensors with porous chromatographic membranes and enhanced sampling capability | |
CN106996951B (en) | Synchronous multi-analyte sensing test paper with sample introduction notch isolated from current interference and application thereof | |
CN101074963A (en) | Electrochemical cholesterol detection electrode test strip and its manufacturing method | |
CN105067685A (en) | Blood multi-component detection test paper and preparation method thereof | |
CN105954336B (en) | A kind of no enzyme superoxide anion electrochemical sensor and its preparation method and application | |
CN107064261A (en) | A kind of biology sensor and detection method based on glucose dehydrogenase | |
CN106124595A (en) | A kind of biosensor and preparation method thereof and reaction reagent | |
CN115266865A (en) | Method for improving stability of electrochemical sensor | |
CN104931560A (en) | Biosensor and preparation method and application thereof | |
CN108548858A (en) | A kind of electrochemistry test paper of quick measurement amylase and its preparation and detection method | |
CN107290417A (en) | A kind of biology sensor for improving reagent crystal habit | |
TWI329738B (en) | ||
CN1349096A (en) | Electrochemical electrode test piece and manufacturing method thereof | |
WO2020062143A1 (en) | Electrochemical sensor and detection device for body fluid detection | |
CN100427940C (en) | Sensor enzyme membrane containing cationic biocompatible polymer and preparation method thereof | |
CN214622434U (en) | Electrochemical biosensor | |
GB2565430A (en) | Biomarker sensor apparatus and method of measuring biomarker in blood | |
KR20200003008A (en) | Biosensors Produced from Enzymes with Reduced Solubility and Methods for Producing and Using Them | |
CN204613145U (en) | A kind of blood sugar test paper | |
CN1296180A (en) | Biochemical sensor with multi-function sampling method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171024 |
|
RJ01 | Rejection of invention patent application after publication |